e-learning
resources
Madrid 2019
Monday, 30.09.2019
COPD treatment: cohorts and real-world studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Real-world medication use patterns in stable COPD patients from Romania
F. Mihaltan (Bucharest, Romania), P. Postolache (Iasi, Romania), O. Arghir (Constanta, Romania), O. Fira-Mladinescu (Timisoara, Romania), A. Silviu (Bucharest, Romania)
Source:
International Congress 2019 – COPD treatment: cohorts and real-world studies
Session:
COPD treatment: cohorts and real-world studies
Session type:
Thematic Poster
Number:
2492
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Mihaltan (Bucharest, Romania), P. Postolache (Iasi, Romania), O. Arghir (Constanta, Romania), O. Fira-Mladinescu (Timisoara, Romania), A. Silviu (Bucharest, Romania). Real-world medication use patterns in stable COPD patients from Romania. 2492
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Data-driven prescription patterns in patients under maintenance treatment for respiratory diseases from the Portuguese prescription database
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014
Dual bronchodilation in real-life COPD management: analysis of patients’ characteristics enrolled in COPD Registry in Russia
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Prescription rates for various classes of COPD & asthma medication in Turkey
Source: Eur Respir J 2001; 18: Suppl. 33, 425s
Year: 2001
Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013
Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Comparison of COPD patients with high and low symptoms from a real-world US survey
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Clinical and inhaled drug profile of COPD patients with indication for beta-blockers who are on beta-blockers
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Prevalence of asthma characteristics in COPD patients in a Dutch well-established asthma/COPD service for primary care
Source: International Congress 2019 – Diagnosis and assessment of airway diseases in primary care
Year: 2019
De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
The drug costs associated with COPD prescription medicine in Denmark
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012
Impact of once-daily single inhaler triple therapy on healthcare resource utilization and associated costs in COPD patients in Spain
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018
Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020
Characteristics of new users of aclidinium, aclidinium/formoterol, and other COPD medications in three European countries
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020
Comparison of hospitalization risk for Medicaid patients with COPD by medication regimen
Source: Eur Respir J 2003; 22: Suppl. 45, 375s
Year: 2003
Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Self-reported medication use in Italian adults: temporal changes and polypharmacy
Source: Eur Respir J 2006; 28: Suppl. 50, 687s
Year: 2006
Use of maintenance medications in patients with insufficiently controlled obstructive airway disease (OAD): the Belgian control survey
Source: Eur Respir J 2002; 20: Suppl. 38, 47s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept